1Church Antion AT.Case clustering in pityriasis rosea:a multicenter epidemiologic study in primary care settings in Hong Kong.Archives of Dermatology,2003,139:489-493.
2Michael B.A remarkable result of a double-masked placebocontrolled trial of erythyomycin in the treatment of pityriasis rosea.Archives of Dermatology,2000,136:775-776.
3Poljacki M,Rajiz N,Matic M.Etiopatogen etski znacaj humanih Herps virvse tip6,7,8 u pojawi nekih oboljenja Koze.Med-Pregl,2001,54:459-463.
4Alba S,Tagami H.Immunohistologic studies in pityriasis rosea;evidence for cellar immune reaction in the lesion epidermis.Arch Dermatol,1985,121:761.
5Okamato H,Imamura S,Aoshima T.et al.Dyskeratotic degeneration of epidermal cells in pityriasis rosea:light and electron studies.Br J Dermatol,1982,207:189.
3Chub AA, Peiris JS. Lack of evidence of HI-IV-7 infection in three cases of pityriasis rosea in children [J]. Pediatr Dermatol, 2001, 18 (5): 381-383.
4Tarore A, Korsaga-Some N, Niamba P, et al. Pityriasis rosea in second schools in Ouagadougou, Burkina Faso [J]. Ann Dermatol Venereol, 2001, 128(5): 605-609.
5Novak Z, Bonis B, Baltas E, et al. Xenon chloride ultraviolet B laser is more effective in treating psoriasis and in inducing T cell apoptosis than narrow-band ultraviolet B [J]. J Photochem Photobiol B, 2002, 67(1): 32-38.
6Piskin G, Tursen U, Sylva-Steenland RM, et al. Clinical improve- ment in chronic plaque-type psoriasis lesions after narrow-band UVB therapy is accompanied by a decrease in the expression of IFN-gamma inducers IL-12, IL-18 and IL-23 [J]. Exp Dermatol, 2004, 13(12): 764-772.
7Bandow GD, Koo JY. Narrow-band ultraviolet B radiation: a review of the current literature [J]. Int J Dermatol, 2004, 43(8): 555-561.
